About the Authors
- Michael Wetter
-
Affiliation GlycoVaxyn AG, Schlieren, Switzerland
- David Goulding
-
Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom
- Derek Pickard
-
Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom
- Michael Kowarik
-
Affiliation GlycoVaxyn AG, Schlieren, Switzerland
- Charles J. Waechter
-
Affiliation Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
- Gordon Dougan
-
Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom
- Michael Wacker
-
* E-mail: michael.wacker@glycovaxyn.com
Affiliation GlycoVaxyn AG, Schlieren, Switzerland
Competing Interests
The authors have read the journal's policy and have the following conflicts: M. Wetter, MK and M. Wacker are all GlycoVaxyn AG employees. M. Wetter, MK and M. Wacker own shares/stock options from GlycoVaxyn AG, and GlycoVaxyn AG was the funder for this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: M. Wetter MK CJW GD M. Wacker. Performed the experiments: M. Wetter DG DP. Analyzed the data: M. Wetter DG DP CJW GD M. Wacker. Contributed reagents/materials/analysis tools: M. Wetter DG DP MK CJW. Wrote the paper: M. Wetter GD M. Wacker.